Pros and cons of cellular studies in developing new drugs for thyroid cancers

Giuliana Salvatore; Francesca Carlomagno; Massimo Santoro

doi:10.1089/thy.2008.1541

Pros and cons of cellular studies in developing new drugs for thyroid cancers

Giuliana Salvatore, Francesca Carlomagno, Massimo Santoro

IRCCS SDN

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	819-822
Number of pages	4
Journal	Thyroid
Volume	18
Issue number	8
DOIs	https://doi.org/10.1089/thy.2008.1541
Publication status	Published - Aug 1 2008

ASJC Scopus subject areas

Endocrinology

Access to Document

10.1089/thy.2008.1541

Cite this

@article{ccb5971328d9410695453dd8138aac2c,

title = "Pros and cons of cellular studies in developing new drugs for thyroid cancers",

author = "Giuliana Salvatore and Francesca Carlomagno and Massimo Santoro",

year = "2008",

month = aug,

day = "1",

doi = "10.1089/thy.2008.1541",

language = "English",

volume = "18",

pages = "819--822",

journal = "Thyroid",

issn = "1050-7256",

publisher = "Mary Ann Liebert Inc.",

number = "8",

}

TY - JOUR

T1 - Pros and cons of cellular studies in developing new drugs for thyroid cancers

AU - Salvatore, Giuliana

AU - Carlomagno, Francesca

AU - Santoro, Massimo

PY - 2008/8/1

Y1 - 2008/8/1

UR - http://www.scopus.com/inward/record.url?scp=50649123215&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=50649123215&partnerID=8YFLogxK

U2 - 10.1089/thy.2008.1541

DO - 10.1089/thy.2008.1541

M3 - Article

C2 - 18690794

AN - SCOPUS:50649123215

VL - 18

SP - 819

EP - 822

JO - Thyroid

JF - Thyroid

SN - 1050-7256

IS - 8

ER -

Pros and cons of cellular studies in developing new drugs for thyroid cancers

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this